Showing results (101-110 of 164) with videos related to

Sort By:
Pageof 17
Nanoscale Research Letters|April 29, 2015
Active site formation mechanism of carbon-based oxygen reduction catalysts derived from a hyperbranched iron phthalocyanine polymerYusuke Hiraike, Makoto Saito, Hideharu Niwa, et al.
Diabetes Care|May 15, 2023
The Broader Economic Value of Treatment for Diabetic Macular EdemaKaren Mulligan, Jaehong Kim, Bryan Tysinger, et al.
The Journal of Allergy and Clinical Immunology|November 17, 2018
Transcriptional and functional diversity of human macrophage repolarizationSina A Gharib, Ryan S McMahan, William E Eddy, et al.
Microbial Cell (Graz, Austria)|March 31, 2017
Biofilm assembly becomes crystal clear - filamentous bacteriophage organize the Pseudomonas aeruginosa biofilm matrix into a liquid crystalPatrick R Secor, Laura K Jennings, Lia A Michaels, et al.
Journal of Leukocyte Biology|August 22, 2013
MMP28 promotes macrophage polarization toward M2 cells and augments pulmonary fibrosisSina A Gharib, Laura K Johnston, Isham Huizar, et al.
Forum for Health Economics & Policy|July 15, 2025
Two Approaches for Measuring Treatment Value Under Uncertainty: Estimating Insurance Value and Risk Preferences in NeurologyJason Shafrin, Kyi-Sin Than, Jacob Fajnor, et al.
Nature Chemical Biology|October 13, 2014
A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammationSanghee Lee, Youngpyo Nam, Ja Young Koo, et al.
Proteoglycan Research|July 3, 2024
Sulfated motifs in heparan sulfate inhibit Streptococcus pneumoniae adhesion onto fibronectin and attenuate corneal infectionAtsuko Hayashida, Hajirah N Saeed, Fuming Zhang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 23, 2025
A Generalized Risk Adjusted Cost Effectiveness (GRACE) Economic Model for Measuring the Value of Interventions that Delay Mobility Impairment Across Neurological ConditionsJason Shafrin, Jaehong Kim, Jacob Fajnor, et al.
Pageof 17